The Story Of Our Firm | En Français | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search
FONT SIZE: A A A A A

Previous Investigations Other Litigations Tequin Research Center

News & Warnings

in this section: FDA Label Changes | Tequin Recall | Tequin Petition

Bookmark This Page Print This Page Email This Page

Tequin Breaking News & Warnings

Antibotic Tequin has recently been found to cause the dangerous side effects hypoglycemia and hyperglycemia. Below are news articles that show the currently research on Tequin. If you or a loved one has suffered due to Tequin use, fill out this simple form for a free case review within 24 hours.

Antibiotic Tequin To Disappear Soon

May. 02, 2006 (kentucky.com)

An antibiotic plagued by serious blood-sugar complications is coming off the market. Bristol-Myers Squibb Co. confirmed yesterday that it plans to stop making and selling Tequin. Spokesman Eric Miller said the company acted after a commercial evaluation of the product, as well as transition in the company's focus.

Study reveals risk to Tequin patients

March 2, 2006 (newsday.com)

Scientists at the Sunnybrook and Women's Science Center in Toronto have studied more than 1,260 patients hospitalized for complications from blood glucose who had received an antibiotic in the 30 days preceding their admission. They looked back to see who among them had received Tequin, the antibiotic in question. Tequin (gatifloxacin), developed by Bristol-Myers Squibb, was federally approved in 1999. About 5,000 prescriptions of the antibiotic are written each day for a variety of bacterial infections. Early on, the company reported some risk for blood-sugar problems, but it was always associated with a history of diabetes and it was not known how common the problem is

Tequin Linked to High Risk of Dangerous Glucose Changes

March 2, 2006 (medpagetoday.com)

TORONTO, March 1 - The antibiotic Tequin (gatifloxacin) has been associated with a sharply elevated rate of hypoglycemia and hyperglycemia when older patients were treated with the agent for infections.

Patients in their 70s treated with Tequin were four times more likely to develop hypoglycemia and 17 times more likely to be hospitalized for hyperglycemia than similar patients treated with Biaxin (clarithromycin) or Zithromax (azithromycin), investigators here reported.

Stronger Warning for Antibiotic Tequin

Feb. 24, 2006 (webmd.com)

The FDA has added a warning against the use of the antibiotic Tequin in people with diabetes after reports of problems with high blood sugar and low blood sugar associated with the drug.



Weitz & Luxenberg is no longer accepting Tequin cases.


see also:

FDA Label Changes Tequin Breaking News - FDA Labeling Changes due to Dangerous Side Effects
FDA requiring Tequin to change label for Warnings about Hypoglycemia

Tequin Recall Tequin - Is Tequin being recalled? Are you being hurt by Tequin?
Tequin Recall - Discover the dangers of Tequin - FREE Tequin Advice

Learn More Tequin Attorney: Tequin Research Center - Learn More about Tequin
Need a Tequin Attorney? FREE Tequin Research Info from Tequin Attorneys

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question
Free Legal Review
Name:
Phone:
Email:
Case Description:
$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.